Robert O. Roswell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert O. Roswell has a total of 418 co-authors. Here are the top co-authors by number of shared publications:
- David A. Morrow
Harvard Medical School
8 shared publications Carlos L. Alviar
The Leon H. Charney Division of Cardiology, New York University School of Medicine, NY (C.L.A., J.N.K.).
6 shared publications- Lori B. Daniels
Division of Cardiovascular Medicine, University of California, San Diego, CA 92037, USA
6 shared publications - David D. Berg
Harvard Medical School
5 shared publications Jason N. Katz
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (L.K.N., J.N.K)
5 shared publicationsNorma Keller
New York University Langone Health, New York, NY
5 shared publications
Latest Publications
- 4 November 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Sex-based differences in the atrial fibrillation care pathway and outcomes: an ITHACA-database analysis
Aims: To characterize sex-specific differences in clinical presentation, evaluate progression through the atrial fibrillation (AF) care pathway from diagnosis to catheter ablation (CA) and assess long-term outcomes. Methods and results: This was a retrospective cohort study of patients with incident AF at Northwell Health between 2015 and 2024 from the ITHACA-database. Sex-specific differences in clinical presentation were examined. The AF care pathway was operationalized as a stepwise cascade, modelling conditional drop-off to identify care gaps. Sex-specific CA risk ratios were assessed via Poisson regression. Incident AF was identified among 165 563/655 459 patients (71.4 ± 11.6 years, 32% non-white, 45% female) with a recorded diagnosis of AF. Women were older (73.3 ± 10.6 vs. 69.8 ± 12.1 years, P < 0.001), had higher rates of dementia (9.1% vs. 5.2%), stroke (8.6% vs. 7.4%) and congestive heart failure (21.5% vs. 20.8%) at diagnosis. Transfer-of-care gaps [median 3.6 years follow-up, 96% retention] were identified at every level: 31.5% of women vs. 35.3% of men were evaluated by cardiology, 16.2% vs. 21.6% by electrophysiology, and 3.5% vs. 5.7% underwent CA (all P < 0.001). Women were 16% less likely to receive CA (RR 0.84 95% CI 0.77–0.91). In cause-specific Cox models, female sex was associated with incident stroke (aHR 1.24, 95% CI 1.18–1.30) and dementia (aHR 1.30, 95% CI 1.24–1.35), but modestly lower mortality after adjustment (aHR 0.96, 95% CI 0.94–0.99). Conclusion: In this real-world analysis, significant sex-specific differences in clinical phenotype at presentation, progression through the AF care pathway and clinical outcomes were observed.
- 4 November 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Sex-based differences in the atrial fibrillation care pathway and outcomes: an ITHACA-database analysis
Aims: To characterize sex-specific differences in clinical presentation, evaluate progression through the atrial fibrillation (AF) care pathway from diagnosis to catheter ablation (CA) and assess long-term outcomes. Methods and results: This was a retrospective cohort study of patients with incident AF at Northwell Health between 2015 and 2024 from the ITHACA-database. Sex-specific differences in clinical presentation were examined. The AF care pathway was operationalized as a stepwise cascade, modelling conditional drop-off to identify care gaps. Sex-specific CA risk ratios were assessed via Poisson regression. Incident AF was identified among 165 563/655 459 patients (71.4 ± 11.6 years, 32% non-white, 45% female) with a recorded diagnosis of AF. Women were older (73.3 ± 10.6 vs. 69.8 ± 12.1 years, P < 0.001), had higher rates of dementia (9.1% vs. 5.2%), stroke (8.6% vs. 7.4%) and congestive heart failure (21.5% vs. 20.8%) at diagnosis. Transfer-of-care gaps [median 3.6 years follow-up, 96% retention] were identified at every level: 31.5% of women vs. 35.3% of men were evaluated by cardiology, 16.2% vs. 21.6% by electrophysiology, and 3.5% vs. 5.7% underwent CA (all P < 0.001). Women were 16% less likely to receive CA (RR 0.84 95% CI 0.77–0.91). In cause-specific Cox models, female sex was associated with incident stroke (aHR 1.24, 95% CI 1.18–1.30) and dementia (aHR 1.30, 95% CI 1.24–1.35), but modestly lower mortality after adjustment (aHR 0.96, 95% CI 0.94–0.99). Conclusion: In this real-world analysis, significant sex-specific differences in clinical phenotype at presentation, progression through the AF care pathway and clinical outcomes were observed.
- 7 May 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (9) , e013778
Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN)
BACKGROUND: The paucity of data to guide selection of specific vasoactive agents in patients with cardiogenic shock (CS) may lead to variability in practice patterns. The level of variability and specific factors that are associated with the use of vasoactive medications and inodilators have not been previously described. METHODS: The CCCTN (Critical Care Cardiology Trials Network) is an international, multicenter network of cardiac intensive care units (CICUs) coordinated by the TIMI Study Group. This analysis included CICU admissions for CS from 2019 to 2023. Variation in the use of inodilator treatment (dobutamine/milrinone) was assessed with multivariable mixed-effects logistic modeling. RESULTS: A total of 3282 admissions from 37 CICUs comprised the analysis cohort. The use of vasoactive medications, including inodilator treatment, varied substantially across institutions. Patient-level variables associated with greater use of inodilators included history of heart failure (odds ratio, 1.98 [95% CI, 1.61–2.44]), biventricular failure (1.59 [95% CI, 1.27–2.00]), Society of Cardiovascular Angiography and Interventions stage D (1.34 [95% CI, 1.07–1.68]), valvular disease (1.34 [95% CI, 1.03–1.74]), and male sex (1.23 [95% CI, 1.02–1.49]). Variables associated with less inodilator use included cardiac arrest (0.33 [95% CI, 0.27–0.42]), right ventricular failure (0.50 [95% CI, 0.33–0.73]), Society of Cardiovascular Angiography and Interventions stage E (0.57 [95% CI, 0.41–0.81]), acute myocardial infarction-CS (0.71 [95% CI, 0.56–0.90]), peripheral arterial disease (0.73 [95% CI, 0.54–0.99]), older age (0.77 [95% CI, 0.72–0.83], per 10-year increase), and estimated glomerular filtration rate (0.96 [95% CI, 0.93–0.99], per 10 mL/min per 1.73 m 2 increase). No individual measurable institution-level factors (eg, transplant center) were associated with variability in inodilator use. In mixed-effects logistic modeling, 45.7% of variation in inodilator use was attributed to patient-level factors and 22.7% to the random effect of individual CICU centers. Similarly, 35.3% of variation in the use of dobutamine versus milrinone was attributed to patient-level factors and 32.6% to the random effect of individual CICU centers. CONCLUSIONS: There is significant variation in vasoactive treatment and inodilator use in CS. Variation in inodilator use was associated with patient-level factors and with substantial individual CICU practice variation. Such variability underscores the need for additional high-quality evidence to guide vasoactive treatment strategies in CS.
- 7 May 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (9) , e013778
Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN)
BACKGROUND: The paucity of data to guide selection of specific vasoactive agents in patients with cardiogenic shock (CS) may lead to variability in practice patterns. The level of variability and specific factors that are associated with the use of vasoactive medications and inodilators have not been previously described. METHODS: The CCCTN (Critical Care Cardiology Trials Network) is an international, multicenter network of cardiac intensive care units (CICUs) coordinated by the TIMI Study Group. This analysis included CICU admissions for CS from 2019 to 2023. Variation in the use of inodilator treatment (dobutamine/milrinone) was assessed with multivariable mixed-effects logistic modeling. RESULTS: A total of 3282 admissions from 37 CICUs comprised the analysis cohort. The use of vasoactive medications, including inodilator treatment, varied substantially across institutions. Patient-level variables associated with greater use of inodilators included history of heart failure (odds ratio, 1.98 [95% CI, 1.61–2.44]), biventricular failure (1.59 [95% CI, 1.27–2.00]), Society of Cardiovascular Angiography and Interventions stage D (1.34 [95% CI, 1.07–1.68]), valvular disease (1.34 [95% CI, 1.03–1.74]), and male sex (1.23 [95% CI, 1.02–1.49]). Variables associated with less inodilator use included cardiac arrest (0.33 [95% CI, 0.27–0.42]), right ventricular failure (0.50 [95% CI, 0.33–0.73]), Society of Cardiovascular Angiography and Interventions stage E (0.57 [95% CI, 0.41–0.81]), acute myocardial infarction-CS (0.71 [95% CI, 0.56–0.90]), peripheral arterial disease (0.73 [95% CI, 0.54–0.99]), older age (0.77 [95% CI, 0.72–0.83], per 10-year increase), and estimated glomerular filtration rate (0.96 [95% CI, 0.93–0.99], per 10 mL/min per 1.73 m 2 increase). No individual measurable institution-level factors (eg, transplant center) were associated with variability in inodilator use. In mixed-effects logistic modeling, 45.7% of variation in inodilator use was attributed to patient-level factors and 22.7% to the random effect of individual CICU centers. Similarly, 35.3% of variation in the use of dobutamine versus milrinone was attributed to patient-level factors and 32.6% to the random effect of individual CICU centers. CONCLUSIONS: There is significant variation in vasoactive treatment and inodilator use in CS. Variation in inodilator use was associated with patient-level factors and with substantial individual CICU practice variation. Such variability underscores the need for additional high-quality evidence to guide vasoactive treatment strategies in CS.
- Open Access
- 26 November 2025
- Published by Wiley in Transfusion
- Vol. 66 (1) , 84-93
Transfusion‐related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial
Background: The aim of this analysis was to quantify and compare the frequency of transfusion‐related adverse events ( TRAE ) in adult patients with myocardial infarction transfused with a restrictive versus liberal transfusion strategy from the Myocardial Ischemia and Transfusion ( MINT ) trial. Study Design and Methods: Clinical sites reported TRAE . Major TRAE were transfusion‐related acute lung injury, transfusion‐associated circulatory overload, acute hemolytic transfusion reaction, anaphylactic transfusion reaction, and transfusion‐associated sepsis. TRAE rates per transfusion arm per patient and per 100 units of red blood cells ( RBC) transfused were calculated. Results: There were nine site‐reported events in the restrictive transfusion arm and 49 events in the liberal transfusion arm with an overall event rate of 0.51 in the restrictive transfusion arm, and 2.80 in the liberal transfusion arm per 100 patients, rate difference ‐2.29; 95% confidence interval [CI], ‐3.12,‐1.44.. The rate of major TRAE was 0.51 in the restrictive arm and 1.99 in the liberal arm per 100 patients, rate difference −1.48 (95% CI , −2.21, −0.74). When the rates were normalized per 100 units of RBC transfused, the rate difference of major TRAE was −0.08 (95% CI , −0.63, 0.46) and rate ratio was 0.90 (95% CI , 0.43, 1.87). Conclusion: The rate of major TRAE was low, albeit increased in the liberal transfusion arm proportional to the number of RBC units transfused. The higher rate of major TRAE in the liberal arm was not sufficient to offset the increased rates of myocardial infarction or death at 30 days observed in patients assigned to the restrictive transfusion arm.
- 26 November 2025
- Published by Wiley in Transfusion
- Vol. 66 (1) , 84-93
Open AccessTransfusion‐related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial
Background: The aim of this analysis was to quantify and compare the frequency of transfusion‐related adverse events ( TRAE ) in adult patients with myocardial infarction transfused with a restrictive versus liberal transfusion strategy from the Myocardial Ischemia and Transfusion ( MINT ) trial. Study Design and Methods: Clinical sites reported TRAE . Major TRAE were transfusion‐related acute lung injury, transfusion‐associated circulatory overload, acute hemolytic transfusion reaction, anaphylactic transfusion reaction, and transfusion‐associated sepsis. TRAE rates per transfusion arm per patient and per 100 units of red blood cells ( RBC) transfused were calculated. Results: There were nine site‐reported events in the restrictive transfusion arm and 49 events in the liberal transfusion arm with an overall event rate of 0.51 in the restrictive transfusion arm, and 2.80 in the liberal transfusion arm per 100 patients, rate difference ‐2.29; 95% confidence interval [CI], ‐3.12,‐1.44.. The rate of major TRAE was 0.51 in the restrictive arm and 1.99 in the liberal arm per 100 patients, rate difference −1.48 (95% CI , −2.21, −0.74). When the rates were normalized per 100 units of RBC transfused, the rate difference of major TRAE was −0.08 (95% CI , −0.63, 0.46) and rate ratio was 0.90 (95% CI , 0.43, 1.87). Conclusion: The rate of major TRAE was low, albeit increased in the liberal transfusion arm proportional to the number of RBC units transfused. The higher rate of major TRAE in the liberal arm was not sufficient to offset the increased rates of myocardial infarction or death at 30 days observed in patients assigned to the restrictive transfusion arm.
- 1 January 2025
- Published by Springer Nature
- p. 201-206
VR-Based Simulation in Medical Education. Empathy: The Next Phase on the Journey to Health Equity
- 1 January 2025
- Published by Springer Nature
- p. 201-206
VR-Based Simulation in Medical Education. Empathy: The Next Phase on the Journey to Health Equity
- Open Access
- 8 October 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (10) , e0311724
Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention
Background: There are disparities in statin therapy for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). The role of structural racism in this disparity has not been examined. Methods: This is a cross-sectional study of participants with ASCVD in the Medical Expenditure Panel Survey from 2014–2017. Mediation analysis is utilized to estimate the direct effect of race and indirect effect of financial resources, access to care, and quality of care on statin usage. Results: The proportion of participants using statins by race/ethnicity were 58.5% for non-Hispanic Whites, 45% for Hispanics, 48.6% for Blacks, 61.6% for Asians, and 46.8% for Others. Statin usage was lower for Hispanics (OR = 0.79, 95% confidence interval [0.65–0.96]) and Blacks (OR = 0.80 [0.66–0.95]) compared to Whites. Hispanic, Black, and Other participants with the same financial resources, access to care, and quality of care as White participants did not have significantly different statin usage compared to White participants (Hispanic: OR = 0.98 [0.79–1.13]; Black (OR = 0.88 [0.76–1.06], Other: OR 0.76, 95% CI [0.56–1.15]). Hispanic, Black, and Other participants had significantly lower statin usage than subjects of the same race but with financial resources, access to care, and quality of care observed in White subjects (Hispanic: OR = 0.83 [0.83–0.92]; Black: OR = 0.91[0.88–0.94]; Other: OR = 0.92 [0.87–0.98]). Discussion: The indirect effect of race and ethnicity on statin therapy are significant but the direct effect of race and ethnicity on statin therapy are insignificant among Blacks and Hispanics compared to non-Hispanic Whites. This suggests that racial disparities in statin therapy are mediated through inequitably distributed resources, suggestive of the impact of structural racism.
- 8 October 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (10) , e0311724
Open AccessFinancial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention
Background: There are disparities in statin therapy for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). The role of structural racism in this disparity has not been examined. Methods: This is a cross-sectional study of participants with ASCVD in the Medical Expenditure Panel Survey from 2014–2017. Mediation analysis is utilized to estimate the direct effect of race and indirect effect of financial resources, access to care, and quality of care on statin usage. Results: The proportion of participants using statins by race/ethnicity were 58.5% for non-Hispanic Whites, 45% for Hispanics, 48.6% for Blacks, 61.6% for Asians, and 46.8% for Others. Statin usage was lower for Hispanics (OR = 0.79, 95% confidence interval [0.65–0.96]) and Blacks (OR = 0.80 [0.66–0.95]) compared to Whites. Hispanic, Black, and Other participants with the same financial resources, access to care, and quality of care as White participants did not have significantly different statin usage compared to White participants (Hispanic: OR = 0.98 [0.79–1.13]; Black (OR = 0.88 [0.76–1.06], Other: OR 0.76, 95% CI [0.56–1.15]). Hispanic, Black, and Other participants had significantly lower statin usage than subjects of the same race but with financial resources, access to care, and quality of care observed in White subjects (Hispanic: OR = 0.83 [0.83–0.92]; Black: OR = 0.91[0.88–0.94]; Other: OR = 0.92 [0.87–0.98]). Discussion: The indirect effect of race and ethnicity on statin therapy are significant but the direct effect of race and ethnicity on statin therapy are insignificant among Blacks and Hispanics compared to non-Hispanic Whites. This suggests that racial disparities in statin therapy are mediated through inequitably distributed resources, suggestive of the impact of structural racism.
- 1 August 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (8) , e010614
Sex Differences in Characteristics, Resource Utilization, and Outcomes of Cardiogenic Shock: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry
BACKGROUND: Sex disparities exist in the management and outcomes of various cardiovascular diseases. However, little is known about sex differences in cardiogenic shock (CS). We sought to assess sex-related differences in the characteristics, resource utilization, and outcomes of patients with CS. METHODS: The Critical Care Cardiology Trials Network is a multicenter registry of advanced cardiac intensive care units (CICUs) in North America. Between 2018 and 2022, each center (N=35) contributed annual 2-month snapshots of consecutive CICU admissions. Patients with CS were stratified as either CS after acute myocardial infarction or heart failure–related CS (HF-CS). Multivariable logistic regression was used for analyses. RESULTS: Of the 22 869 admissions in the overall population, 4505 (20%) had CS. Among 3923 patients with CS due to ventricular failure (32% female), 1235 (31%) had CS after acute myocardial infarction and 2688 (69%) had HF-CS. Median sequential organ failure assessment scores did not differ by sex. Women with HF-CS had shorter CICU lengths of stay (4.5 versus 5.4 days; P P P P <0.0001) compared with men. Women with HF-CS had higher in-hospital mortality than men, even after adjusting for age, illness severity, and comorbidities (34% versus 23%; odds ratio, 1.76 [95% CI, 1.42–2.17]). In contrast, there were no significant sex differences in utilization of advanced CICU monitoring and interventions, or mortality, among patients with CS after acute myocardial infarction. CONCLUSIONS: Women with HF-CS had lower use of pulmonary artery catheters and mechanical circulatory support, shorter CICU lengths of stay, and higher in-hospital mortality than men, even after accounting for age, illness severity, and comorbidities. These data highlight the need to identify underlying reasons driving the differences in treatment decisions, so outcomes gaps in HF-CS can be understood and eliminated.
- 1 August 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (8) , e010614
Sex Differences in Characteristics, Resource Utilization, and Outcomes of Cardiogenic Shock: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry
BACKGROUND: Sex disparities exist in the management and outcomes of various cardiovascular diseases. However, little is known about sex differences in cardiogenic shock (CS). We sought to assess sex-related differences in the characteristics, resource utilization, and outcomes of patients with CS. METHODS: The Critical Care Cardiology Trials Network is a multicenter registry of advanced cardiac intensive care units (CICUs) in North America. Between 2018 and 2022, each center (N=35) contributed annual 2-month snapshots of consecutive CICU admissions. Patients with CS were stratified as either CS after acute myocardial infarction or heart failure–related CS (HF-CS). Multivariable logistic regression was used for analyses. RESULTS: Of the 22 869 admissions in the overall population, 4505 (20%) had CS. Among 3923 patients with CS due to ventricular failure (32% female), 1235 (31%) had CS after acute myocardial infarction and 2688 (69%) had HF-CS. Median sequential organ failure assessment scores did not differ by sex. Women with HF-CS had shorter CICU lengths of stay (4.5 versus 5.4 days; P P P P <0.0001) compared with men. Women with HF-CS had higher in-hospital mortality than men, even after adjusting for age, illness severity, and comorbidities (34% versus 23%; odds ratio, 1.76 [95% CI, 1.42–2.17]). In contrast, there were no significant sex differences in utilization of advanced CICU monitoring and interventions, or mortality, among patients with CS after acute myocardial infarction. CONCLUSIONS: Women with HF-CS had lower use of pulmonary artery catheters and mechanical circulatory support, shorter CICU lengths of stay, and higher in-hospital mortality than men, even after accounting for age, illness severity, and comorbidities. These data highlight the need to identify underlying reasons driving the differences in treatment decisions, so outcomes gaps in HF-CS can be understood and eliminated.
- 14 March 2024
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 390 (11) , 1030-1043
Case 8-2024: A 55-Year-Old Man with Cardiac Arrest, Cardiogenic Shock, and Hypoxemia
- 14 March 2024
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 390 (11) , 1030-1043
Case 8-2024: A 55-Year-Old Man with Cardiac Arrest, Cardiogenic Shock, and Hypoxemia
- Open Access
- 5 March 2024
- Published by American Medical Association (AMA) in JAMA
- Vol. 331 (9) , 727-728
Maintenance of Certification—The Value to Patients and Physicians
This Viewpoint discusses the ABIM’s continuing efforts to innovate and streamline maintenance of certification, including the recently launched Longitudinal Knowledge Assessment (LKA), to better accommodate physicians’ schedules and desires for flexibility.
- 5 March 2024
- Published by American Medical Association (AMA) in JAMA
- Vol. 331 (9) , 727-728
Open AccessMaintenance of Certification—The Value to Patients and Physicians
This Viewpoint discusses the ABIM’s continuing efforts to innovate and streamline maintenance of certification, including the recently launched Longitudinal Knowledge Assessment (LKA), to better accommodate physicians’ schedules and desires for flexibility.
- 1 January 2024
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 177 (1) , 70-82
Adoption of Internal Medicine Milestone Ratings and Changes in Bias Against Black, Latino, and Asian Internal Medicine Residents
The 2014 adoption of the Milestone ratings system may have affected evaluation bias against minoritized groups. To assess bias in internal medicine (IM) residency knowledge ratings against Black or Latino residents-who are underrepresented in medicine (URiM)-and Asian residents before versus after Milestone adoption in 2014. Cross-sectional and interrupted time-series comparisons. U.S. IM residencies. 59 835 IM residents completing residencies during 2008 to 2013 and 2015 to 2020. Adoption of the Milestone ratings system. Pre-Milestone (2008 to 2013) and post-Milestone (2015 to 2020) bias was estimated as differences in standardized knowledge ratings between U.S.-born and non-U.S.-born minoritized groups versus non-Latino U.S.-born White (NLW) residents, with adjustment for performance on the American Board of Internal Medicine IM certification examination and other physician characteristics. Interrupted time-series analysis measured deviations from pre-Milestone linear bias trends. During the pre-Milestone period, ratings biases against minoritized groups were large (-0.40 SDs [95% CI, -0.48 to -0.31 SDs; P < 0.001] for URiM residents, -0.24 SDs [CI, -0.30 to -0.18 SDs; P < 0.001] for U.S.-born Asian residents, and -0.36 SDs [CI, -0.45 to -0.27 SDs; P < 0.001] for non-U.S.-born Asian residents). These estimates decreased to less than -0.15 SDs after adoption of Milestone ratings for all groups except U.S.-born Black residents, among whom substantial (though lower) bias persisted (-0.26 SDs [CI, -0.36 to -0.17 SDs; P < 0.001]). Substantial deviations from pre-Milestone linear bias trends coincident with adoption of Milestone ratings were also observed. Unobserved variables correlated with ratings bias and Milestone ratings adoption, changes in identification of race/ethnicity, and generalizability to Milestones 2.0. Knowledge ratings bias against URiM and Asian residents was ameliorated with the adoption of the Milestone ratings system. However, substantial ratings bias against U.S.-born Black residents persisted. None.
- 1 January 2024
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 177 (1) , 70-82
Adoption of Internal Medicine Milestone Ratings and Changes in Bias Against Black, Latino, and Asian Internal Medicine Residents
The 2014 adoption of the Milestone ratings system may have affected evaluation bias against minoritized groups. To assess bias in internal medicine (IM) residency knowledge ratings against Black or Latino residents-who are underrepresented in medicine (URiM)-and Asian residents before versus after Milestone adoption in 2014. Cross-sectional and interrupted time-series comparisons. U.S. IM residencies. 59 835 IM residents completing residencies during 2008 to 2013 and 2015 to 2020. Adoption of the Milestone ratings system. Pre-Milestone (2008 to 2013) and post-Milestone (2015 to 2020) bias was estimated as differences in standardized knowledge ratings between U.S.-born and non-U.S.-born minoritized groups versus non-Latino U.S.-born White (NLW) residents, with adjustment for performance on the American Board of Internal Medicine IM certification examination and other physician characteristics. Interrupted time-series analysis measured deviations from pre-Milestone linear bias trends. During the pre-Milestone period, ratings biases against minoritized groups were large (-0.40 SDs [95% CI, -0.48 to -0.31 SDs; P < 0.001] for URiM residents, -0.24 SDs [CI, -0.30 to -0.18 SDs; P < 0.001] for U.S.-born Asian residents, and -0.36 SDs [CI, -0.45 to -0.27 SDs; P < 0.001] for non-U.S.-born Asian residents). These estimates decreased to less than -0.15 SDs after adoption of Milestone ratings for all groups except U.S.-born Black residents, among whom substantial (though lower) bias persisted (-0.26 SDs [CI, -0.36 to -0.17 SDs; P < 0.001]). Substantial deviations from pre-Milestone linear bias trends coincident with adoption of Milestone ratings were also observed. Unobserved variables correlated with ratings bias and Milestone ratings adoption, changes in identification of race/ethnicity, and generalizability to Milestones 2.0. Knowledge ratings bias against URiM and Asian residents was ameliorated with the adoption of the Milestone ratings system. However, substantial ratings bias against U.S.-born Black residents persisted. None.
- 1 September 2023
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 16 (9) , e010084
Family Engagement in the Adult Cardiac Intensive Care Unit: A Survey of Family Engagement Practices in the Cardiac Critical Care Trials Network
BACKGROUND: Cardiovascular and critical care professional societies recommend incorporating family engagement practices into routine clinical care. However, little is known about current family engagement practices in contemporary cardiac intensive care units (CICUs). METHODS: We implemented a validated 12-item family engagement practice survey among site investigators participating in the Critical Care Cardiology Trials Network, a collaborative network of CICUs in North America. The survey includes 9 items assessing specific engagement practices, 1 item about other family-centered care practices, and 2 open-ended questions on strategies and barriers concerning family engagement practice. We developed an engagement practice score by assigning 1 point for each family engagement practice partially or fully adopted at each site (max score 9). We assessed for relationships between the engagement practice score and CICU demographics. RESULTS: All sites (N=39; 100%) completed the survey. The most common family engagement practices were open visitation (95%), information and support to families (85%), structured care conferences (n=82%), and family participation in rounds (77%). The median engagement practice score was 5 (interquartile range, 4). There were no differences in engagement practice scores by geographic region or CICU type. The most commonly used strategies to promote family engagement were family presence during rounds (41%), communication (28%), and family meetings (28%). The most common barriers to family engagement were COVID-related visitation policies (38%) and resource limitations (13%). CONCLUSIONS: Family engagement practices are routinely performed in many CICUs; however, considerable variability exists. There is a need for strategies to address the variability of family engagement practices in CICUs.
- 1 September 2023
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 16 (9) , e010084
Family Engagement in the Adult Cardiac Intensive Care Unit: A Survey of Family Engagement Practices in the Cardiac Critical Care Trials Network
BACKGROUND: Cardiovascular and critical care professional societies recommend incorporating family engagement practices into routine clinical care. However, little is known about current family engagement practices in contemporary cardiac intensive care units (CICUs). METHODS: We implemented a validated 12-item family engagement practice survey among site investigators participating in the Critical Care Cardiology Trials Network, a collaborative network of CICUs in North America. The survey includes 9 items assessing specific engagement practices, 1 item about other family-centered care practices, and 2 open-ended questions on strategies and barriers concerning family engagement practice. We developed an engagement practice score by assigning 1 point for each family engagement practice partially or fully adopted at each site (max score 9). We assessed for relationships between the engagement practice score and CICU demographics. RESULTS: All sites (N=39; 100%) completed the survey. The most common family engagement practices were open visitation (95%), information and support to families (85%), structured care conferences (n=82%), and family participation in rounds (77%). The median engagement practice score was 5 (interquartile range, 4). There were no differences in engagement practice scores by geographic region or CICU type. The most commonly used strategies to promote family engagement were family presence during rounds (41%), communication (28%), and family meetings (28%). The most common barriers to family engagement were COVID-related visitation policies (38%) and resource limitations (13%). CONCLUSIONS: Family engagement practices are routinely performed in many CICUs; however, considerable variability exists. There is a need for strategies to address the variability of family engagement practices in CICUs.